 Smith Nephew PLCs LON:SN growth drivers are underappreciated according to analysts at Credit Suisse, who have upgraded the stock to outperform from neutral and upped their target price to 1,805p from 1,560p. In a note on Wednesday, the bank said investors underestimate the combined power of recently-acquired growth drivers with corresponding return leverage mid term and that they expected the medical equipment groups stock to reverse its material underperformance over the past 12 months. 